Company profile for HAYA Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company’s discovery engine focuses on long non-coding RNAs (lncRNAs) within the “dark matter” of the human genome -- key tissue and cell-specific drivers of fibrosis and other disease...
HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company’s discovery engine focuses on long non-coding RNAs (lncRNAs) within the “dark matter” of the human genome -- key tissue and cell-specific drivers of fibrosis and other disease processes -- to identify novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
SuperLab Suisse - Bâtiment Serine Route de la Corniche 6 1066 Epalinges, Laus...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250603780426/en/HAYA-Therapeutics-Moves-San-Diego-Operations-to-Lilly-Gateway-Labs-to-Accelerate-Development-of-RNA-Guided-Therapeutics-Platform

BUSINESSWIRE
03 Jun 2025

https://www.businesswire.com/news/home/20250508776403/en/HAYA-Therapeutics-Raises-%2465-Million-in-Series-A-Funding-to-Deliver-Precision-RNA-Guided-Medicines-for-Chronic-and-Age-Related-Diseases

BUSINESSWIRE
08 May 2025

https://www.businesswire.com/news/home/20250502322005/en/HAYA-Therapeutics-to-Present-on-RNA-Guided-Regulatory-Genome-Platform-at-the-Annual-Meeting-of-the-American-Society-of-Gene-Cell-Therapy-ASGCT

BUSINESSWIRE
02 May 2025

https://www.businesswire.com/news/home/20250313318056/en/HAYA-Therapeutics-Appoints-Former-Exscientia-Executive-Dr.-Richard-Law-as-Chief-Business-Officer

BUSINESSWIRE
13 Mar 2025

https://www.businesswire.com/news/home/20240911282552/en

BUSINESSWIRE
11 Sep 2024

https://www.businesswire.com/news/home/20240904516481/en

BUSINESSWIRE
05 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty